Aimei Health Technology Co Ltd

Research Aimei Health Technology Co Ltd (AFJK) on Bullrun: valuation model: 54.9% overvalued, market cap USD 87.20M, P/E 166.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAFJK
• ExchangeNASDAQ
• CountryUnited States
• SectorFinancial Services
• IndustryShell Companies
• CurrencyUSD
• Valuation signal54.9% overvalued
• Market capUSD 87.20M
• P/E166.8
• Financial periodFY2025
• Net incomeUSD 1.06M

Valuation Snapshot

Bullrun's latest valuation model marks Aimei Health Technology Co Ltd as 54.9% overvalued; latest market cap is USD 87.20M; P/E is 166.8.

About Aimei Health Technology Co Ltd

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Frequently asked questions

Is Aimei Health Technology Co Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Aimei Health Technology Co Ltd as 54.9% overvalued.

What is Aimei Health Technology Co Ltd's market cap?

Aimei Health Technology Co Ltd's market capitalization is USD 87.20M.

What is Aimei Health Technology Co Ltd's P/E ratio?

Aimei Health Technology Co Ltd's price-to-earnings (P/E) ratio is 166.8.

What does Aimei Health Technology Co Ltd do?

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses.